Bifidobacterium longum subsp. infantis B8762 modulates the infant gut-lung axis via microbial and metabolic reprogramming.
- 2026-06
- RCT · n = 115
- Microbial pathogenesis 215
- Rui Ma
- Bo Jia
- Xiangyang Zhang
- Zhixin Zhao
- Feiyan Zhao
- Min-Tze Liong
- Adli Ali
- Intan Juliana Abd Hamid
- Taufiq Hidayat Hasan
- Fahisham Taib
- Zhihong Sun
- PubMed: 41802657
- DOI: 10.1016/j.micpath.2026.108431
- High evidence
Bifidobacterium longum subsp. infantis B8762 has shown clinical efficacy in reducing such infections, but its mechanistic basis remains unclear.
- Effect
- Beneficial
- Effect size
- Moderate